LAS VEGAS, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Protect Pharmaceuticals Corporation (OTC: PRTT), a Nevada Corporation, officially announces the launch of a new business model.
Protect Pharmaceutical along with a consortium of businesses have entered into an agreement that will result in the creation of the Property Tobit Exchange business model. While no assurances can be provided it is intended that going-forward Property Tobit Exchange shall become the operating model and produce cash flow which shall sustain the enterprise. PRTT will be headquartered in Las Vegas and will be able to share the expertise and other resources of the consortium. PRTT intends to change its name following the acquisition of certain strategic assets from consortium members to the Property Tobit Exchange Corporation.
PRTT’s mission statement is to “Deliver the power of the blockchain into the collective hands of the community.” PRTT is focused on delivering innovative and empowering real estate based solutions and models for urban cities that are based on improving the lives of all community stakeholders. PRTT’s goal is to inject silicon valley style innovation and new financial platforms into urban real estate markets. The first platform will be a national smart contract based two-sided marketplace for urban real estate whose transactions can be executed in dollars or cryptocurrency. The platform will include the tokenization of urban real estate as a method of expanding ownership and urban revitalization. The PRTT consortium is committed to developing and/or repurposing over 1,000,000 properties in cities across America during the next 10 years to create environmentally, socially and economically sustainable communities.
Yvette Sanchez CEO of J & Y Property Preservation shared, “This is a big step forward for all of us as we just celebrated our 10 year anniversary having transformed more than 10,000 housing units and have transitioned our business model to become a company applying decades of experience in real estate to new technologies and methodologies based on the creation of an interconnected human and digital blockchain. Our goal with PRTT is to engage and support diverse workers, entrepreneurs, and investors in the construction of a new urban economy anchored by real estate but simultaneously and exponentially launching real estate based technology companies on the blockchain. We believe the urban housing landscape has changed forever with our entry to the marketplace.”
Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the SEC including the Current Reports on Form 8-K and the Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For more information contact:
Protect Pharmaceutical Corporation